Evexia Lifecare Limited

As of June 30, 2026, Evexia Lifecare Limited carries a market capitalization of 3.14B, placing it among publicly traded companies globally. Its enterprise value stands at 3.14B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Evexia Lifecare Limited has 1.88B shares outstanding.

As of June 30, 2026, Evexia Lifecare Limited trades at a trailing price-to-earnings ratio of 174.88.

As of June 30, 2026, Evexia Lifecare Limited trades at an EV/EBITDA multiple of 156.73 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.64 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 217.90 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.14B versus a market cap of 3.14B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 131.83M in revenue per employee across its workforce of 9.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Evexia Lifecare Limited recorded 5.04M in income tax expense. That works out to an effective tax rate of 21.31, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 23.66M, leaving 18.62M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Evexia Lifecare Limited's stock has declined approximately 8.08% over the past 52 weeks. The 50-day moving average sits at 1.71, while the 200-day moving average is 1.48.

Over the twelve months ended June 30, 2026, Evexia Lifecare Limited generated 1.19B in revenue and converted that into 18.62M in net income, yielding earnings per share of 0.01. EBITDA reached 20.00M, while operating income came in at 14.39M.

Over the twelve months ended June 30, 2026, Evexia Lifecare Limited posted a gross margin of 3.80, reflecting its pricing power and cost economics. The operating margin of 1.21 and net profit margin of 1.57 provide insight into operational efficiency.

Evexia Lifecare Limited's most recent stock split took place on May 24, 2022 with a 1:2 split ratio.